Consejo Nacional de Salud

27 Weigert G, Zawinka C, Resch H, Schmetterer
L, Garhöfer G, Intravenous Administration of Diphenhydramine
Reduces Histamine-Induced Vasodilator
Effects in the Retina and Choroid, Investigative
Ophthalmology & Visual Science, March
2006, Vol. 47, No. 3
28 Banerji A, Long AA, Camargo CA Jr., Diphenhydramine
versus nonsedating antihistamines for
acute allergic reactions: a literature review,
Allergy Asthma Proc. 2007 Jul-Aug;28(4):418-26.
Review. PMID: 17883909 [PubMed - indexed for
MEDLINE
29 USP-DI 2007, Vol.1, 333:337, 27ed, Thomson, Micromedex,
Mass. USA.
30 Kaiser HB, Gopalan G, Chung W Loratadine provides
early symptom control in seasonal allergic
rhinitis,. Allergy Asthma Proc. 2008 Oct 1. [Epub
ahead of print]
PMID: 18831859 [PubMed - as supplied by
publisher]
31 Goebel MU, Meykadeh N, Kou W, Schedlowski
M, Hengge UR, Behavioral conditioning of antihistamine
effects in patients with allergic rhinitis
Psychother Psychosom. 2008;77(4):227-34. Epub
2008 Apr 16. PMID: 18418029 [PubMed - indexed
for MEDLINE
32 Pons-Guiraud A, Nekam K, Lahovsky J, Costa
A, Piacentini A., Emedastine difumarate versus
loratadine in chronic idiopathic urticaria: a randomized,
double-blind, controlled European multicentre
clinical trial, Eur J Dermatol. 2006 Nov-
Dec;16(6):649-54., PMID: 17229605 [PubMed
- indexed for MEDLINE]
33 Soll RF, Morley CJ. Prophylactic versus selective
use of surfactant in preventing morbidity and
mortality in preterm infants. Cochrane Database
of Systematic Reviews 2001, Issue 2. Art. No.:
CD000510. DOI: 10.1002/14651858.CD000510.
34 Multiple versus single dose natural surfactant
extract for severe neonatal respiratory distress
syndrome. Cochrane Database of Systematic
Reviews 1999, Issue 2. Art. No.: CD000141. DOI:
10.1002/14651858.CD000141.
35 Soll RF, Synthetic surfactant for respiratory distress
syndrome in preterm infants. Cochrane
Database of Systematic Reviews 1998, Issue 3.
Art. No.: CD001149. DOI: 10.1002/14651858.
CD001149
36 Ryan G, Mukhopadhyay S, Singh M. Nebulised
anti-pseudomonal antibiotics for cystic
fibrosis. Cochrane Database of Systematic Reviews
2003, Issue 3. Art. No.: CD001021. DOI:
10.1002/14651858.CD001021
37 Ramsey WB, et al Intermittent administration of
inhaled tobramycin in patients with cystic fibrosis.
Cystic Fibrosis Inhaled Tobramycin Study Group N
Eng J Med 1999; 340: 23-30
38 Wood DM, Smyth AR. Antibiotic strategies for
eradicating Pseudomonas aeruginosa in people
with cystic fibrosis. Cochrane Database of Systematic
Reviews 2006, Issue 1. Art. No.: CD004197.
DOI: 10.1002/14651858.CD004197.pub2
39 Doring G et al, Antibiotic therapy against Pseudomonas
aeruginosa in cystic fibrosis: an european consensus,
Eur Respir J, 2000. 16: 749-767
GRUPO R | Sistema respiratorio
535
R